Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Lysosome	4/128	1.1733860979334071e-05	0.00010560474881400665	42.70967741935484	-110.50319683107625	ARSB;ASAH1;CTSA;NEU1
KEGG_2021_Human	Sphingolipid metabolism	3/49	2.4431897858988954e-05	0.0001099435403654503	74.73913043478261	-127.19676357023239	ASAH1;CERS2;NEU1
KEGG_2021_Human	Sphingolipid signaling pathway	2/119	0.008964014539605185	0.026892043618815555	16.98931623931624	-22.939511285821055	ASAH1;CERS2
KEGG_2021_Human	Glycosaminoglycan degradation	1/19	0.023286116400967973	0.03616176437699378	49.69135802469136	-23.981021494289497	ARSB
KEGG_2021_Human	Other glycan degradation	1/18	0.022072807228795267	0.03616176437699378	52.62091503267974	-25.018935329511017	NEU1
KEGG_2021_Human	Renin-angiotensin system	1/23	0.028125816737661832	0.03616176437699378	40.63636363636363	-20.601670877696893	CTSA
KEGG_2021_Human	Terpenoid backbone biosynthesis	1/22	0.026917919418171	0.03616176437699378	42.576719576719576	-21.34946103825324	DHDDS
KEGG_2021_Human	Glycosphingolipid biosynthesis	1/45	0.05436047130022726	0.061155530212755674	20.262626262626263	-11.690056551619103	A4GALT
KEGG_2021_Human	Axon guidance	1/182	0.2038826300760579	0.2038826300760579	4.841620626151013	-2.6265948500338347	SEMA6B
